SCHEMBL1213477

SCHEMBL1213477

CN(Cc1c(F)cccc1Cl)S(=O)(=O)c1cc(-c2ccnn2-c2ccccc2F)c(O)cc1O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 7/20 0.49
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 3/20 0.36
PDE10A Q9Y233 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NR3C2 P08235 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
RXFP1 Q9HBX9 1/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1217262 0.96 HSP90AA1 (0.47) HSP90AA1NPC1ALDH1A1POLBMAPT
SCHEMBL1219000 0.94 HSP90AA1 (0.46) HSP90AA1NPC1ALDH1A1POLBMAPT
SCHEMBL1219566 0.90 HSP90AA1 (0.50) HSP90AA1ALDH1A1PDE10ANR3C2MEN1
SCHEMBL1219026 0.87 HSP90AA1 (0.48) HSP90AA1ALDH1A1PDE10AMAPTLMNA
SCHEMBL1217812 0.87 HSP90AA1 (0.50) HSP90AA1POLBNR3C2MEN1KMT2A
SCHEMBL1219682 0.86 HSP90AA1 (0.53) HSP90AA1ALDH1A1PDE10APOLBMAPT
SCHEMBL1216909 0.86 HSP90AA1 (0.53) HSP90AA1PDE10APOLBNR3C2MEN1
SCHEMBL1217998 0.85 HSP90AA1 (0.50) HSP90AA1ALDH1A1PDE10ANR3C2MEN1
SCHEMBL1219638 0.85 HSP90AA1 (0.52) HSP90AA1PDE10APOLBNR3C2RXFP1
SCHEMBL1219470 0.85 HSP90AA1 (0.52) HSP90AA1ALDH1A1PDE10ANR3C2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028485-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS EGGENWEILER HANS-MICHAEL 2011-02-03 US claimed
US-20090325974-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS MERCK PATENT GESELLSCHAFT (DE) 2009-12-31 US claimed
US-7906657-B2 1,5-diphenylpyrazoles II as HSP90 inhibitors MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2011-03-15 US disclosed
US-20110028485-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS EGGENWEILER HANS-MICHAEL 2011-02-03 US disclosed
US-20090325974-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS MERCK PATENT GESELLSCHAFT (DE) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325974-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885NPC1 1107/4885ALDH1A1 979/4885
US-20110028485-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885NPC1 1107/4885ALDH1A1 979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.